Retrospective evaluation of patients after radiosurgery or radiotherapy for multiple brain metastases at LMU and UKE Hamburg

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034132

Enrollment

200

Registered

2024-07-22

Start date

2023-04-19

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C79.3

Interventions

Group 1: Patients with brain metastases who received cranial stereotactic radiosurgery or hypofractionated stereotactic radiotherapy in the radiation oncology departments of LMU Hospital Munich or UKE

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: At least 2 cerebral metastases from a malignant melanoma or lung carcinoma Cranial stereotactic radiosurgery or hypofractionated stereotactic radiotherapy Minimum follow-up of 3 months using cMRI

Exclusion criteria

Exclusion criteria: Brain metastases from entities other than melanoma or lung carcinoma

Design outcomes

Primary

Measure	Time frame
local control	—

Secondary

Measure	Time frame
Radiation Necrosis	—

Countries

Germany

Contacts

Public ContactMaximilian Niyazi

LMU Klinikum München

maximilian.niyazi@med.uni-muenchen.de089 4400 73770

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026